Copyright Reports & Markets. All rights reserved.

Global Companion Animal Drugs Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Companion Animal Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Antibiotics and Antimicrobials
    • 1.2.3 Parasiticides
    • 1.2.4 Others
  • 1.3 Market by Application
    • 1.3.1 Global Companion Animal Drugs Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Dogs
    • 1.3.3 Cats
    • 1.3.4 Horses
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Companion Animal Drugs Market Perspective (2016-2027)
  • 2.2 Companion Animal Drugs Growth Trends by Regions
    • 2.2.1 Companion Animal Drugs Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Companion Animal Drugs Historic Market Share by Regions (2016-2021)
    • 2.2.3 Companion Animal Drugs Forecasted Market Size by Regions (2022-2027)
  • 2.3 Companion Animal Drugs Industry Dynamic
    • 2.3.1 Companion Animal Drugs Market Trends
    • 2.3.2 Companion Animal Drugs Market Drivers
    • 2.3.3 Companion Animal Drugs Market Challenges
    • 2.3.4 Companion Animal Drugs Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Companion Animal Drugs Players by Revenue
    • 3.1.1 Global Top Companion Animal Drugs Players by Revenue (2016-2021)
    • 3.1.2 Global Companion Animal Drugs Revenue Market Share by Players (2016-2021)
  • 3.2 Global Companion Animal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Companion Animal Drugs Revenue
  • 3.4 Global Companion Animal Drugs Market Concentration Ratio
    • 3.4.1 Global Companion Animal Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Companion Animal Drugs Revenue in 2020
  • 3.5 Companion Animal Drugs Key Players Head office and Area Served
  • 3.6 Key Players Companion Animal Drugs Product Solution and Service
  • 3.7 Date of Enter into Companion Animal Drugs Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Companion Animal Drugs Breakdown Data by Type

  • 4.1 Global Companion Animal Drugs Historic Market Size by Type (2016-2021)
  • 4.2 Global Companion Animal Drugs Forecasted Market Size by Type (2022-2027)

5 Companion Animal Drugs Breakdown Data by Application

  • 5.1 Global Companion Animal Drugs Historic Market Size by Application (2016-2021)
  • 5.2 Global Companion Animal Drugs Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Companion Animal Drugs Market Size (2016-2027)
  • 6.2 North America Companion Animal Drugs Market Size by Type
    • 6.2.1 North America Companion Animal Drugs Market Size by Type (2016-2021)
    • 6.2.2 North America Companion Animal Drugs Market Size by Type (2022-2027)
    • 6.2.3 North America Companion Animal Drugs Market Size by Type (2016-2027)
  • 6.3 North America Companion Animal Drugs Market Size by Application
    • 6.3.1 North America Companion Animal Drugs Market Size by Application (2016-2021)
    • 6.3.2 North America Companion Animal Drugs Market Size by Application (2022-2027)
    • 6.3.3 North America Companion Animal Drugs Market Size by Application (2016-2027)
  • 6.4 North America Companion Animal Drugs Market Size by Country
    • 6.4.1 North America Companion Animal Drugs Market Size by Country (2016-2021)
    • 6.4.2 North America Companion Animal Drugs Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Companion Animal Drugs Market Size (2016-2027)
  • 7.2 Europe Companion Animal Drugs Market Size by Type
    • 7.2.1 Europe Companion Animal Drugs Market Size by Type (2016-2021)
    • 7.2.2 Europe Companion Animal Drugs Market Size by Type (2022-2027)
    • 7.2.3 Europe Companion Animal Drugs Market Size by Type (2016-2027)
  • 7.3 Europe Companion Animal Drugs Market Size by Application
    • 7.3.1 Europe Companion Animal Drugs Market Size by Application (2016-2021)
    • 7.3.2 Europe Companion Animal Drugs Market Size by Application (2022-2027)
    • 7.3.3 Europe Companion Animal Drugs Market Size by Application (2016-2027)
  • 7.4 Europe Companion Animal Drugs Market Size by Country
    • 7.4.1 Europe Companion Animal Drugs Market Size by Country (2016-2021)
    • 7.4.2 Europe Companion Animal Drugs Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Companion Animal Drugs Market Size (2016-2027)
  • 8.2 Asia-Pacific Companion Animal Drugs Market Size by Type
    • 8.2.1 Asia-Pacific Companion Animal Drugs Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Companion Animal Drugs Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Companion Animal Drugs Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Companion Animal Drugs Market Size by Application
    • 8.3.1 Asia-Pacific Companion Animal Drugs Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Companion Animal Drugs Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Companion Animal Drugs Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Companion Animal Drugs Market Size by Region
    • 8.4.1 Asia-Pacific Companion Animal Drugs Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Companion Animal Drugs Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Companion Animal Drugs Market Size (2016-2027)
  • 9.2 Latin America Companion Animal Drugs Market Size by Type
    • 9.2.1 Latin America Companion Animal Drugs Market Size by Type (2016-2021)
    • 9.2.2 Latin America Companion Animal Drugs Market Size by Type (2022-2027)
    • 9.2.3 Latin America Companion Animal Drugs Market Size by Type (2016-2027)
  • 9.3 Latin America Companion Animal Drugs Market Size by Application
    • 9.3.1 Latin America Companion Animal Drugs Market Size by Application (2016-2021)
    • 9.3.2 Latin America Companion Animal Drugs Market Size by Application (2022-2027)
    • 9.3.3 Latin America Companion Animal Drugs Market Size by Application (2016-2027)
  • 9.4 Latin America Companion Animal Drugs Market Size by Country
    • 9.4.1 Latin America Companion Animal Drugs Market Size by Country (2016-2021)
    • 9.4.2 Latin America Companion Animal Drugs Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Companion Animal Drugs Market Size (2016-2027)
  • 10.2 Middle East & Africa Companion Animal Drugs Market Size by Type
    • 10.2.1 Middle East & Africa Companion Animal Drugs Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Companion Animal Drugs Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Companion Animal Drugs Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Companion Animal Drugs Market Size by Application
    • 10.3.1 Middle East & Africa Companion Animal Drugs Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Companion Animal Drugs Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Companion Animal Drugs Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Companion Animal Drugs Market Size by Country
    • 10.4.1 Middle East & Africa Companion Animal Drugs Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Companion Animal Drugs Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Zoetis
    • 11.1.1 Zoetis Company Details
    • 11.1.2 Zoetis Business Overview
    • 11.1.3 Zoetis Companion Animal Drugs Introduction
    • 11.1.4 Zoetis Revenue in Companion Animal Drugs Business (2016-2021)
    • 11.1.5 Zoetis Recent Development
  • 11.2 Bayer
    • 11.2.1 Bayer Company Details
    • 11.2.2 Bayer Business Overview
    • 11.2.3 Bayer Companion Animal Drugs Introduction
    • 11.2.4 Bayer Revenue in Companion Animal Drugs Business (2016-2021)
    • 11.2.5 Bayer Recent Development
  • 11.3 Boehringer Ingelheim
    • 11.3.1 Boehringer Ingelheim Company Details
    • 11.3.2 Boehringer Ingelheim Business Overview
    • 11.3.3 Boehringer Ingelheim Companion Animal Drugs Introduction
    • 11.3.4 Boehringer Ingelheim Revenue in Companion Animal Drugs Business (2016-2021)
    • 11.3.5 Boehringer Ingelheim Recent Development
  • 11.4 Eli Lilly
    • 11.4.1 Eli Lilly Company Details
    • 11.4.2 Eli Lilly Business Overview
    • 11.4.3 Eli Lilly Companion Animal Drugs Introduction
    • 11.4.4 Eli Lilly Revenue in Companion Animal Drugs Business (2016-2021)
    • 11.4.5 Eli Lilly Recent Development
  • 11.5 Merck
    • 11.5.1 Merck Company Details
    • 11.5.2 Merck Business Overview
    • 11.5.3 Merck Companion Animal Drugs Introduction
    • 11.5.4 Merck Revenue in Companion Animal Drugs Business (2016-2021)
    • 11.5.5 Merck Recent Development
  • 11.6 Vetoquinol
    • 11.6.1 Vetoquinol Company Details
    • 11.6.2 Vetoquinol Business Overview
    • 11.6.3 Vetoquinol Companion Animal Drugs Introduction
    • 11.6.4 Vetoquinol Revenue in Companion Animal Drugs Business (2016-2021)
    • 11.6.5 Vetoquinol Recent Development
  • 11.7 Virbac
    • 11.7.1 Virbac Company Details
    • 11.7.2 Virbac Business Overview
    • 11.7.3 Virbac Companion Animal Drugs Introduction
    • 11.7.4 Virbac Revenue in Companion Animal Drugs Business (2016-2021)
    • 11.7.5 Virbac Recent Development
  • 11.8 Dechra Pharmaceuticals
    • 11.8.1 Dechra Pharmaceuticals Company Details
    • 11.8.2 Dechra Pharmaceuticals Business Overview
    • 11.8.3 Dechra Pharmaceuticals Companion Animal Drugs Introduction
    • 11.8.4 Dechra Pharmaceuticals Revenue in Companion Animal Drugs Business (2016-2021)
    • 11.8.5 Dechra Pharmaceuticals Recent Development
  • 11.9 Ceva Sante Animale
    • 11.9.1 Ceva Sante Animale Company Details
    • 11.9.2 Ceva Sante Animale Business Overview
    • 11.9.3 Ceva Sante Animale Companion Animal Drugs Introduction
    • 11.9.4 Ceva Sante Animale Revenue in Companion Animal Drugs Business (2016-2021)
    • 11.9.5 Ceva Sante Animale Recent Development
  • 11.10 Aratana Therapeutics
    • 11.10.1 Aratana Therapeutics Company Details
    • 11.10.2 Aratana Therapeutics Business Overview
    • 11.10.3 Aratana Therapeutics Companion Animal Drugs Introduction
    • 11.10.4 Aratana Therapeutics Revenue in Companion Animal Drugs Business (2016-2021)
    • 11.10.5 Aratana Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Companion Animal Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Companion Animal Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Antibiotics and Antimicrobials
    Parasiticides
    Others

    Segment by Application
    Dogs
    Cats
    Horses
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Zoetis
    Bayer
    Boehringer Ingelheim
    Eli Lilly
    Merck
    Vetoquinol
    Virbac
    Dechra Pharmaceuticals
    Ceva Sante Animale
    Eli Lilly

    Buy now